Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - OPERATING EXPENSES
Operating Expenses PRPH - ProPhase Labs, Inc.
37.9 M
LAST VALUE
28.25%
2 YEAR CAGR
42.62%
5 YEAR CAGR
8.82%
10 YEAR CAGR